RUA.L
RUA Life Sciences plc
LSEGBpEQUITY
Healthcare
DELAYED
Last price
26.00
■ 0.00 (0.00%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
26.80
Prev close
26.00
Day high
26.90
Day low
26.03
Volume
63.51K
Market cap
$16.14M
P/E (TTM)
—
52W range
10.42 – 28.90
Day trading desk
Gap from prior close
+3.08%
Prior close 26.00
VWAP
26.71
-2.66% from price
Relative volume
0.39×
Quiet session
Session range
3.46%
26.00 – 26.90
Position in range
0%
Near session low
ATR (14D)
1.38
5.31% of price
Prior day high
26.93
PDH
Prior day low
25.80
PDL
Bid / ask spread
—
Quote not published
Session volume
56.81K
Avg 146.99K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-1.89%
-0.5%
1M
+13.04%
+9.3%
3M
+30.00%
+26.9%
6M
+92.59%
+81.5%
YTD
+85.71%
+73.4%
1Y
+114.43%
+94.4%
3Y
+38.67%
-35.5%
5Y
-77.87%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on RUA.L open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
11.89M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jun 1, 26 | Dowgate Capital Limited |
— | 3.71M | — | Direct |
| Mar 31, 26 | Dowgate Capital Limited |
— | 0 | — | Direct |
| Mar 31, 26 | Bradshaw (Mark Anthony James) |
— | 0 | — | Direct |
| Mar 31, 26 | Charles Stanley Group PLC |
— | 0 | — | Direct |
| Mar 31, 26 | Rathbone Brothers & Company |
— | 0 | — | Direct |
| Mar 31, 26 | Titcomb (Clive James) |
— | 0 | — | Direct |
| Dec 31, 25 | Rathbone Brothers & Company |
— | 0 | — | Direct |
| Dec 31, 25 | Richmond (David) |
— | 0 | — | Direct |
| Dec 31, 25 | Titcomb (Clive James) |
— | 0 | — | Direct |
| Dec 31, 25 | Dowgate Capital Limited |
— | 0 | — | Direct |
| Dec 31, 25 | Bradshaw (Mark Anthony James) |
— | 0 | — | Direct |
| Dec 31, 25 | Charles Stanley Group PLC |
— | 0 | — | Direct |
| Oct 1, 25 | Bradshaw (Mark Anthony James) |
— | 0 | — | Direct |
| Oct 1, 25 | Charles Stanley Group PLC |
— | 0 | — | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
Ardill (Ian Leslie) |
— | 272.73K | Annual Return |
Bradshaw (Mark Anthony James) |
— | 2.56M | Annual Return |
Brown (William Donald) |
— | 906.88K | Annual Return |
Charles Stanley Group PLC |
— | 2.18M | Annual Return |
Dowgate Capital Limited |
— | 3.07M | Decrease |
Mc-Kenna (John) |
— | 109.69K | Annual Return |
Rathbone Brothers & Company |
— | 3.95M | Annual Return |
Richmond (David) |
— | 1.53M | Annual Return |
Smith (Lachlan Arthur) |
— | 130.48K | Annual Return |
Titcomb (Clive James) |
— | 4.25M | Annual Return |
Fundamentals
Market cap$16.14M
Enterprise value$14.46M
Revenue (TTM)$4.62M
Gross profit$3.61M
EBITDA$575.00K
Net income$281.67K
EPS (TTM)$0.00
Free cash flow—
Total cash$2.37M
Total debt$651.00K
Book value / share$0.11
Shares outstanding62.06M
Float50.42M
Short % of float—
Dividend yield—
Beta (5Y)0.97
Valuation & profitability ratios
Trailing P/E—
Forward P/E-65.00
PEG ratio—
Price / sales—
Price / book230.09
EV / revenue3.13
EV / EBITDA25.15
Gross margin78.20%
Operating margin-8.52%
Profit margin6.10%
Return on equity—
Return on assets—
Debt / equity9.25
Current ratio5.92
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|
| Total revenue | $2.19M | $2.18M | $1.63M | +0.6% |
| Operating revenue | $2.19M | $2.18M | $1.63M | +0.6% |
| Cost of revenue | $415.00K | $388.00K | $267.00K | +7.0% |
| Gross profit | $1.78M | $1.79M | $1.36M | -0.8% |
| Research & development | $873.00K | $1.07M | $911.00K | -18.6% |
| Selling, general & admin | $1.16M | $1.11M | $1.33M | +4.1% |
| Total operating expense | $3.73M | $4.10M | $3.71M | -9.1% |
| Operating income | -$1.95M | -$2.31M | -$2.35M | +15.5% |
| Net interest income | -$83.00K | -$16.00K | -$8.00K | -418.8% |
| Pre-tax income | -$2.02M | -$2.32M | -$2.36M | +13.0% |
| Tax provision | -$580.00K | -$319.00K | -$293.00K | -81.8% |
| Net income | -$1.44M | -$2.00M | -$2.07M | +28.1% |
| Net income to common | -$1.44M | -$2.00M | -$2.07M | +28.1% |
| Basic EPS | -0.04 | -0.09 | -0.09 | +52.5% |
| Diluted EPS | -0.04 | -0.09 | -0.09 | +52.5% |
| EBIT | -$1.95M | -$2.31M | -$2.35M | +15.5% |
| EBITDA | -$1.59M | -$1.95M | -$2.04M | +18.6% |
| Basic shares | 62.06M | 22.18M | 22.18M | +179.7% |
| Diluted shares | 62.06M | 22.18M | 22.18M | +179.7% |
| Line item | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|
| Cash & equivalents | $3.93M | $1.48M | $2.96M | +164.9% |
| Cash & short-term investments | $3.93M | $1.48M | $2.96M | +164.9% |
| Accounts receivable | $301.00K | $175.00K | $216.00K | +72.0% |
| Inventory | $112.00K | $81.00K | $124.00K | +38.3% |
| Total current assets | $4.99M | $2.15M | $4.21M | +131.9% |
| Property, plant & equipment | $2.46M | $2.74M | $2.60M | -10.3% |
| Goodwill & intangibles | $720.00K | $771.00K | $822.00K | -6.6% |
| Total assets | $8.17M | $5.66M | $7.63M | +44.3% |
| Total current liabilities | $554.00K | $414.00K | $511.00K | +33.8% |
| Current debt | $31.00K | $29.00K | $23.00K | +6.9% |
| Long-term debt | $132.00K | $165.00K | $199.00K | -20.0% |
| Total debt | $389.00K | $475.00K | $344.00K | -18.1% |
| Total liabilities | $987.00K | $980.00K | $1.04M | +0.7% |
| Retained earnings | -$19.98M | -$18.55M | -$16.54M | -7.8% |
| Shareholder equity | $7.18M | $4.68M | $6.58M | +53.4% |
| Working capital | $4.44M | $1.74M | $3.70M | +155.3% |
| Net tangible assets | $6.46M | $3.91M | $5.76M | +65.2% |
| Shares issued | 62.06M | 22.18M | 22.18M | +179.7% |
| Line item | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|
| Net income | -$1.44M | -$2.00M | -$2.07M | +28.1% |
| Depreciation & amortisation | $364.00K | $358.00K | $312.00K | +1.7% |
| Stock-based compensation | -$35.00K | $102.00K | $145.00K | -134.3% |
| Change in working capital | -$289.00K | $167.00K | -$545.00K | -273.1% |
| Operating cash flow | -$1.33M | -$1.15M | -$2.35M | -15.9% |
| Capital expenditure | -$55.00K | -$449.00K | -$904.00K | +87.8% |
| Investing cash flow | -$85.00K | -$477.00K | -$912.00K | +82.2% |
| Financing cash flow | $3.89M | $132.00K | -$66.00K | +2,845.5% |
| Free cash flow | -$1.38M | -$1.59M | -$3.26M | +13.3% |
| End cash position | $3.93M | $1.48M | $2.96M | +164.9% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | -0.00 | 1 | $5.21M | -22.1% |
| Next year | — | — | $0 | — |
Analyst targets & ownership
Mean target$50.00
High target$50.00
Low target$50.00
Implied upside92.31%
Analyst count1
ConsensusNONE
Strong buy / Buy0 / 1
Hold0
Sell / Strong sell0 / 0
Held by insiders19.16%
Held by institutions17.58%
Institutions holding7
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
25.90
+0.39% from price
SMA 20
25.18
+3.28% from price
SMA 50
22.68
+14.64% from price
SMA 100
20.86
+24.67% from price
SMA 200
17.08
+52.20% from price
EMA 12
25.63
+1.45% from price
EMA 26
24.71
+5.20% from price
EMA 50
23.32
+11.51% from price
RSI (14)
64.3
Neutral
MACD (12,26,9)
0.91
Hist -0.04
ATR (14)
1.38
5.31% of price
Realised vol 30D
47.1%
Annualised
Bollinger upper
27.18
20, 2σ
Bollinger lower
23.17
20, 2σ
50 / 200 cross
Golden
22.68 vs 17.08
Trend bias
Above 200
+52.20%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.32
Less volatile than market
Correlation to SPY
0.08
Largely independent
Realised vol 30D
47.1%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-30.4%
Peak to trough
Max drawdown 5Y
-94.7%
Peak to trough
ATR 14
1.38
5.31% of price
Beta (reported)
0.97
5Y monthly, from filing
Dividends & splits
Forward rate—
Forward yield—
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split1:10
Split dateSep 1, 2003
Headlines
Amorim starts Serie A life with Milan win, Juve edge Frosinone
AFP · 12m ago
Lawsuit filed in Napali coast ‘doors-off’ helicopter tour crash
The Honolulu Star-Advertiser · 13m ago
Does Billionaire Bill Ackman Know Something Wall Street Doesn’t? He Invested in These 2 Stocks That Have Dropped 33% and 18% Over the Past Year
Motley Fool · 14m ago
Liquor industry struggles grow with another Chapter 7 filing
TheStreet · 16m ago
Raphinha, Lopez hit braces as Barcelona trounce Elche
AFP · 16m ago
Media Advisory: Housing Announcement in Toronto
CNW Group · 19m ago
Dow Jones Futures Due With Market At Key Point; Nvidia, Tariffs, Warsh In Focus
Investor's Business Daily · 25m ago
Axsome Therapeutics Stock Is Up 16% Year to Date. Why Wall Street Thinks It Has Even More Room to Run
Motley Fool · 29m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.